Lawrence B. Cohen’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,497
| Closed | -$2.78M | – | 52 |
|
|
2023
Q3 | $2.78M | Buy |
5,497
+17
| +0.3% | +$9.06K | 1.88% | 20 |
|
|
2023
Q2 | $2.86M | Sell |
5,480
-35
| -0.6% | -$18.9K | 1.83% | 16 |
|
|
2023
Q1 | $3.18M | Buy |
5,515
+19
| +0.3% | +$10.7K | 2.13% | 10 |
|
|
2022
Q4 | $3.03M | Buy |
5,496
+103
| +2% | +$54.6K | 1.58% | 15 |
|
|
2022
Q3 | $2.73M | Sell |
5,393
-803
| -13% | -$449K | 2.11% | 8 |
|
|
2022
Q2 | $3.37M | Sell |
6,196
-111
| -2% | -$61.1K | 2.4% | 9 |
|
|
2022
Q1 | $3.73M | Buy |
6,307
+205
| +3% | +$118K | 2.21% | 10 |
|
|
2021
Q4 | $4.07M | Sell |
6,102
-2,979
| -33% | -$1.86M | 1.59% | 13 |
|
|
2021
Q3 | $5.19M | Sell |
9,081
-650
| -7% | -$357K | 2.74% | 6 |
|
|
2021
Q2 | $4.91M | Sell |
9,731
-160
| -2% | -$75.5K | 2.5% | 8 |
|
|
2021
Q1 | $4.51M | Buy |
9,891
+6
| +0.1% | +$2.86K | 2.45% | 10 |
|
|
2020
Q4 | $4.6M | Sell |
9,885
-144
| -1% | -$67.5K | 2.56% | 9 |
|
|
2020
Q3 | $4.43M | Buy |
10,029
+193
| +2% | +$79.7K | 2.69% | 8 |
|
|
2020
Q2 | $3.56M | Buy |
9,836
+37
| +0.4% | +$12.4K | 2.38% | 11 |
|
|
2020
Q1 | $2.78M | Sell |
9,799
-3,144
| -24% | -$991K | 2.18% | 15 |
|
|
2019
Q4 | $4.2M | Buy |
12,943
+1,874
| +17% | +$568K | 2.48% | 10 |
|
|
2019
Q3 | $3.22M | Buy |
11,069
+884
| +9% | +$253K | 2.11% | 16 |
|
|
2019
Q2 | $2.99M | Buy |
10,185
+195
| +2% | +$53.7K | 2.07% | 18 |
|
|
2019
Q1 | $2.73M | Buy |
9,990
+169
| +2% | +$42.1K | 1.92% | 25 |
|
|
2018
Q4 | $2.2M | Buy |
9,821
+185
| +2% | +$43.4K | 1.71% | 28 |
|
|
2018
Q3 | $2.35M | Sell |
9,636
-550
| -5% | -$127K | 1.6% | 30 |
|
|
2018
Q2 | $2.11M | Sell |
10,186
-330
| -3% | -$70K | 1.51% | 32 |
|
|
2018
Q1 | $2.17M | Sell |
10,516
-1,138
| -10% | -$239K | 1.46% | 32 |
|
|
2017
Q4 | $2.21M | Sell |
11,654
-335
| -3% | -$64.2K | 1.4% | 31 |
|
|
2017
Q3 | $2.27M | Sell |
11,989
-635
| -5% | -$115K | 1.48% | 31 |
|
|
2017
Q2 | $2.2M | Sell |
12,624
-715
| -5% | -$120K | 1.41% | 32 |
|
|
2017
Q1 | $2.05M | Sell |
13,339
-385
| -3% | -$58.8K | 1.26% | 29 |
|
|
2016
Q4 | $1.94M | Sell |
13,724
-511
| -4% | -$75.3K | 1.18% | 28 |
|
|
2016
Q3 | $2.26M | Buy |
14,235
+195
| +1% | +$30K | 1.35% | 25 |
|
|
2016
Q2 | $2.08M | Buy |
14,040
+3,945
| +39% | +$582K | 1.24% | 25 |
|
|
2016
Q1 | $1.43M | Sell |
10,095
-15
| -0.1% | -$2.01K | 0.94% | 31 |
|
|
2015
Q4 | $1.43M | Buy |
10,110
+445
| +5% | +$59.4K | 0.97% | 31 |
|
|
2015
Q3 | $1.18M | Buy |
9,665
+424
| +5% | +$55.2K | 0.82% | 31 |
|
|
2015
Q2 | $1.2M | Sell |
9,241
-425
| -4% | -$55.4K | 0.76% | 31 |
|
|
2015
Q1 | $1.3M | Sell |
9,666
-307
| -3% | -$39.6K | 0.79% | 30 |
|
|
2014
Q4 | $1.25M | Sell |
9,973
-1,657
| -14% | -$201K | 0.75% | 32 |
|
|
2014
Q3 | $1.42M | Sell |
11,630
-325
| -3% | -$39.5K | 0.93% | 30 |
|
|
2014
Q2 | $1.41M | Sell |
11,955
-930
| -7% | -$109K | 0.93% | 29 |
|
|
2014
Q1 | $1.55M | Sell |
12,885
-325
| -2% | -$38.6K | 1.07% | 29 |
|
|
2013
Q4 | $1.47M | Sell |
13,210
-950
| -7% | -$94.5K | 1.05% | 29 |
|
|
2013
Q3 | $1.3M | Sell |
14,160
-5,210
| -27% | -$471K | 0.99% | 29 |
|
|
2013
Q2 | $1.64M | Buy |
+19,370
| New | +$1.61M | 1.21% | 29 |
|
Other funds holding TMO
Lawrence B. Cohen's TMO Position: Q4 2023 in Review
Lawrence B. Cohen sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 5,497 shares — an estimated $2.78M sold.
Lawrence B. Cohen first reported a position in TMO in Q2 2013 and held it in 42 quarters. The position peaked at $5.19M in Q3 2021. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Lawrence B. Cohen reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
- Lawrence B. Cohen sold 5,497 Thermo Fisher Scientific shares in Q4 2023, an estimated $2.78M.
- Lawrence B. Cohen first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 42 quarters.
- Lawrence B. Cohen's Thermo Fisher Scientific position peaked at $5.19M in Q3 2021.
- 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.